KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Exchange Rate Effect: 2009-2024

Historic Exchange Rate Effect for Acadia Pharmaceuticals (ACAD) over the last 16 years, with Dec 2024 value amounting to -$94,000.

  • Acadia Pharmaceuticals' Exchange Rate Effect rose 700.00% to $24,000 in Q2 2025 from the same period last year, while for Jun 2025 it was -$83,000, marking a year-over-year decrease of 937.50%. This contributed to the annual value of -$94,000 for FY2024, which is 422.22% down from last year.
  • Latest data reveals that Acadia Pharmaceuticals reported Exchange Rate Effect of -$94,000 as of FY2024, which was down 422.22% from -$18,000 recorded in FY2023.
  • Acadia Pharmaceuticals' 5-year Exchange Rate Effect high stood at $7,000 for FY2021, and its period low was -$94,000 during FY2024.
  • In the last 3 years, Acadia Pharmaceuticals' Exchange Rate Effect had a median value of -$18,000 in 2023 and averaged -$35,333.
  • Per our database at Business Quant, Acadia Pharmaceuticals' Exchange Rate Effect plummeted by 500.00% in 2020 and then soared by 187.50% in 2021.
  • Acadia Pharmaceuticals' Exchange Rate Effect (Yearly) stood at -$8,000 in 2020, then skyrocketed by 187.50% to $7,000 in 2021, then fell by 14.29% to $6,000 in 2022, then crashed by 400.00% to -$18,000 in 2023, then slumped by 422.22% to -$94,000 in 2024.